U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...

COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...